Warren Buffett fit · Grandes empresas a preço justo
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Warren Buffett Stock?
Low Buffett fit — meets only 3/9 criteria; valuation, moat, or financial health flags risk.
20/100
FNão encaixa
3/9 critérios atendidos
Os critérios de Warren Buffett, aplicados a GYRE
ROIC ≥ 15%
chave11.7%
Gross margin ≥ 40%
chave95.5%
Owner earnings yield ≥ 5%
chave1.2%
5y profitable
chave
Como GYRE pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$731.67M
P/L (TTM)
55.7x
ROIC (TTM)
11.69%
Margem bruta
95.48%
Perguntas frequentes
What is GYRE's Warren Buffett fit score?
GYRE scores 20/100 on our Warren Buffett fit engine — grade F. Low Buffett fit — meets only 3/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own GYRE?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends GYRE.
How often is this score updated?
GYRE's Warren Buffett fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Warren Buffett possua ou recomende GYRE pessoalmente.